This section will feature a weekly report which generated a lot of interest when it was first featured on the Medical Breakthroughs site. Come back weekly to read each highlight as we "Play It Again!"
Reported April 2015
Melanoma Drug: Life-Saver and Game-Changer!
LOS ANGELES. (Ivanhoe Newswire) -- More than 76,000 new cases of melanoma will be diagnosed this year, and about 10,000 people in the U.S. will die from this form of skin cancer. Until now, there was no hope for melanoma that spread to other areas of the body. For the first time, a new drug is changing the game and saving lives.
Three years ago, Tom Stutz could barely move, let alone play tennis. Stutz told Ivanhoe, “I didn’t play for about a year and a half.”
Tom had melanoma that spread to his lungs, liver, spine, and shoulder, leaving him in constant pain.
He said, “It got to the point where I was put on oxygen 24-7.”
Even his best tennis buddies thought Tom’s days on the court were over.
Tom Mertens, Tom Stutz’s friend told Ivanhoe, “I saw him in a wheelchair, 24-hour care, and I said to myself, I don’t think he’s going to last a month.”
Every medicine Tom tried failed, until he enrolled in a clinical trial at UCLA to test a brand new therapy called Keytruda.
Antoni Ribas, MD, PhD, Professor of Medicine at UCLA, David Geffen School of Medicine, told Ivanhoe, “I think it is a game changer.”
Keytruda is given as an infusion every three weeks. It targets a protein that allows the immune system to attack the cancer. The FDA approved the drug as a “breakthrough therapy” after a Phase I trial showed 72-percent of patients had their tumors shrink.
“And it’s not growing back many months later,” Dr. Ribas explained.
Tom’s tumors are 15-percent their original size. His friends are amazed by his recovery.
Mertens said, “I’m flabbergasted, stupefied, and thankful!”
Stutz told Ivanhoe, “I feel great.”
Dr. Ribas says it’s very unusual for a drug to be approved by the FDA after a Phase I trial. Typically, medicines are approved after Phase II or III studies. The therapy may also help lung, bladder, and head and neck cancers, but researchers say further study is needed.
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas, firstname.lastname@example.org.